[ALA] QoQ Quarter Result on 31-Mar-2022 [#Q3]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
30-Mar-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q3]
Profit Trend
QoQ- 40.89%
YoY- -41.52%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 380 714 273 137 23 11 15 757.50%
PBT -4,948 -1,950 -4,671 -2,335 -3,950 -1,975 -3,923 16.68%
Tax -1,049 0 -0 0 -0 0 -623 41.39%
NP -3,899 -1,950 -4,671 -2,335 -3,950 -1,975 -3,300 11.72%
Tax Rate - - - - - - - -
Total Cost 4,279 2,664 4,944 2,472 3,973 1,986 3,315 18.49%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -1,027.21 -272.98 -1,709.47 -1,709.48 -17,484.78 -17,484.01 -22,288.88 -87.07%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.01 -0.00 -0.01 -0.00 -0.01 -0.00 -0.01 0.00%
EPS Diluted -0.01 -0.00 -0.01 -0.00 -0.01 -0.00 -0.01 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.